Simulations Plus ROE 2010-2024 | SLP
Current and historical return on equity (ROE) values for Simulations Plus (SLP) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Simulations Plus ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2024-02-29 |
$0.01B |
$0.18B |
6.40% |
| 2023-11-30 |
$0.01B |
$0.17B |
6.51% |
| 2023-08-31 |
$0.01B |
$0.17B |
5.85% |
| 2023-05-31 |
$0.01B |
$0.17B |
5.78% |
| 2023-02-28 |
$0.01B |
$0.17B |
5.71% |
| 2022-11-30 |
$0.01B |
$0.18B |
5.64% |
| 2022-08-31 |
$0.01B |
$0.18B |
6.89% |
| 2022-05-31 |
$0.01B |
$0.18B |
6.42% |
| 2022-02-28 |
$0.01B |
$0.17B |
6.55% |
| 2021-11-30 |
$0.01B |
$0.17B |
6.06% |
| 2021-08-31 |
$0.01B |
$0.17B |
5.54% |
| 2021-05-31 |
$0.01B |
$0.17B |
6.88% |
| 2021-02-28 |
$0.01B |
$0.16B |
7.66% |
| 2020-11-30 |
$0.01B |
$0.16B |
8.96% |
| 2020-08-31 |
$0.01B |
$0.16B |
12.72% |
| 2020-05-31 |
$0.01B |
$0.05B |
21.82% |
| 2020-02-29 |
$0.01B |
$0.04B |
23.38% |
| 2019-11-30 |
$0.01B |
$0.04B |
24.49% |
| 2019-08-31 |
$0.01B |
$0.04B |
25.71% |
| 2019-05-31 |
$0.01B |
$0.04B |
23.88% |
| 2019-02-28 |
$0.01B |
$0.03B |
21.71% |
| 2018-11-30 |
$0.01B |
$0.03B |
25.81% |
| 2018-08-31 |
$0.01B |
$0.03B |
26.89% |
| 2018-05-31 |
$0.01B |
$0.03B |
28.32% |
| 2018-02-28 |
$0.01B |
$0.03B |
29.91% |
| 2017-11-30 |
$0.01B |
$0.03B |
23.53% |
| 2017-08-31 |
$0.01B |
$0.03B |
20.41% |
| 2017-05-31 |
$0.01B |
$0.03B |
21.05% |
| 2017-02-28 |
$0.01B |
$0.02B |
21.74% |
| 2016-11-30 |
$0.01B |
$0.02B |
22.73% |
| 2016-08-31 |
$0.01B |
$0.02B |
23.53% |
| 2016-05-31 |
$0.00B |
$0.02B |
19.51% |
| 2016-02-29 |
$0.00B |
$0.02B |
20.00% |
| 2015-11-30 |
$0.00B |
$0.02B |
20.25% |
| 2015-08-31 |
$0.00B |
$0.02B |
20.78% |
| 2015-05-31 |
$0.00B |
$0.02B |
22.22% |
| 2015-02-28 |
$0.00B |
$0.02B |
17.65% |
| 2014-11-30 |
$0.00B |
$0.02B |
19.05% |
| 2014-08-31 |
$0.00B |
$0.02B |
20.34% |
| 2014-05-31 |
$0.00B |
$0.02B |
20.69% |
| 2014-02-28 |
$0.00B |
$0.01B |
21.43% |
| 2013-11-30 |
$0.00B |
$0.01B |
21.43% |
| 2013-08-31 |
$0.00B |
$0.01B |
21.05% |
| 2013-05-31 |
$0.00B |
$0.01B |
20.69% |
| 2013-02-28 |
$0.00B |
$0.01B |
20.00% |
| 2012-11-30 |
$0.00B |
$0.02B |
19.67% |
| 2012-08-31 |
$0.00B |
$0.02B |
19.67% |
| 2012-05-31 |
$0.00B |
$0.02B |
20.00% |
| 2012-02-29 |
$0.00B |
$0.02B |
20.69% |
| 2011-11-30 |
$0.00B |
$0.02B |
21.43% |
| 2011-08-31 |
$0.00B |
$0.01B |
22.64% |
| 2011-05-31 |
$0.00B |
$0.01B |
23.08% |
| 2011-02-28 |
$0.00B |
$0.01B |
23.53% |
| 2010-11-30 |
$0.00B |
$0.01B |
24.49% |
| 2010-08-31 |
$0.00B |
$0.01B |
16.67% |
| 2010-05-31 |
$0.00B |
$0.01B |
17.39% |
| 2010-02-28 |
$0.00B |
$0.01B |
18.18% |
| 2009-11-30 |
$0.00B |
$0.01B |
9.30% |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Computer Software |
$0.912B |
$0.060B |
|
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.
|
